(19)
(11) EP 0 462 229 A1

(12)

(43) Date of publication:
27.12.1991 Bulletin 1991/52

(21) Application number: 90907676.0

(22) Date of filing: 27.04.1990
(51) International Patent Classification (IPC): 
A61K 38/ 04( . )
A61K 39/ 21( . )
C07K 7/ 04( . )
C07K 7/ 08( . )
C07K 14/ 73( . )
 A61K 38/ 17( . )
C07K 7/ 02( . )
C07K 7/ 06( . )
C07K 7/ 50( . )
A61K 38/ 00( . )
(86) International application number:
PCT/US1990/002360
(87) International publication number:
WO 1990/013562 (15.11.1990 Gazette 1990/26)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB IT LI LU NL SE

(30) Priority: 02.05.1989 US 19890346159
03.04.1990 US 19900503832

(71) Applicants:
  • GENELABS INCORPORATED
    Redwood City, CA 94063 (US)
  • EIDEN, Lee E.
    Bethesda, MD 20814 (US)
  • FRASER, Blair
    Darnestown, MD 20878 (US)
  • NARA, Peter L.
    Frederick, MD 21701 (US)

(72) Inventors:
  • EIDEN, Lee, E.
    Bethesda, MD 20814 (US)
  • FRASER, Blair
    MD 20878 (US)
  • NARA, Peter, L.
    Frederick, MD 21701 (US)
  • LIFSON, Jeffrey, D.
    Menlo Park, CA 94025 (US)
  • HWANG, Kou
    Danville, CA 94526 (US)

(74) Representative: Harrison, David Christopher, et al 
MEWBURN ELLIS York House 23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)

   


(54) CHEMICALLY MODIFIED CD4 PEPTIDE FRAGMENTS HAVING ANTI-RETROVIRAL PROPERTIES